The Nomination Committee’s proposal ahead of the Annual General Meeting of Hemfosa Fastigheter AB (publ)
The Nomination Committee of Hemfosa Fastigheter comprises Mats Andersson for the Fourth Swedish National Pension Fund, Christer Wachtmeister for Kåpan Pensioner, Ramsay Brufer for Alecta, Eva Gottfridsdotter-Nilsson for Länsförsäkringar Fondförvaltning AB and Bengt Kjell, Chairman of the Board of Hemfosa Fastigheter. The Nomination Committee proposes the following ahead of the 2015 Annual General Meeting:
The Nomination Committee proposes that Bengt Kjell, Magnus Eriksson, Anneli Lindblom, Daniel Skoghäll, Caroline Sundewall, Ulrika Valassi and Jens Engwall be re-elected as Board members. Furthermore, the Committee proposes re-election of Bengt Kjell as Chairman of the Board. The Nomination Committee’s proposals mean that the number of Board members will remain unchanged over the forthcoming mandate period.
The Nomination Committee also proposes re-election of KPMG as auditors.
All of the Nomination Committee’s proposals will be presented in the notice of the Annual General Meeting and, in parallel, the Nomination Committee’ statement explaining its recommendation for the Board’s composition will be published on the company’s website. Hemfosa Fastigheter’s Annual General Meeting will take place at 3:00 p.m. on May 7, 2015, at the Hotell Rival, Mariatorget 3 in Stockholm.
For further information, please contact:
Bengt Kjell, Chairman of the Board, firstname.lastname@example.org, mobile phone +46 70 6945 3968
About Hemfosa Fastigheter
Hemfosa is a Swedish real estate company with a well-balanced and geographically diversified property portfolio focusing on community service properties with the State and municipalities as the largest tenants. This provides stable cash flows and a healthy yield. In conjunction with value creation, Hemfosa also aims to actively participate in the transaction market. At September 30, 2014, Hemfosa owned commercial properties in Sweden with a total property value of approximately SEK 20.5 billion, including the company’s share of the property value of joint ventures. The company’s share has been listed on Nasdaq Stockholm Mid Cap since March 21, 2014. Read more at www.hemfosa.se .